Skip to main content
. 2016 May 10;18(10):1390–1401. doi: 10.1093/neuonc/now089

Fig. 4.

Fig. 4.

Analysis of mixed lymphocyte-tumor cells mediated antitumor immune response. Cellular immunity was evaluated in splenocytes from cured mice from experiment shown in Fig. 2B. xCELLigence real-time cell impedance analysis monitoring mixed lymphocyte-tumor cells mediated antitumor immune response shows splenocytes from cured mice activated against Tu-2449 cells mediate effector:target cell ratio–dependent killing. (*P < .05, **P < .0001).